Clinical Supply Planning Articles

1. Inside GCSG 2026: Clinical Supply Impact On Patient Experience 5/21/2026

   This GCSG 2026 event recap with Steve Jacobs (including video) highlights how clinical testing and supply decisions shape patient experience, among other buzzy topics.

2. U.S. Policy Drift And The Shift In Clinical Trial Supply Leadership 5/21/2026

   China's clinical trial system now outpaces the U.S., exposing regulatory delays that ripple into supply planning, manufacturing windows, and drug development speed. 

3. Building Resilient Clinical Trial Supply Chains In An Era Of Geopolitical Risk 5/20/2026

   Geopolitical disruption is reshaping clinical trial supply chains. Learn how sponsors use visibility, AI, and contingency planning to avoid delays.

4. Site-Level Execution In Clinical Trials: Where Systems Break Down 5/19/2026

   When site workflows break down, clinical trial supply risks follow. A CRA explains how delays, system gaps, and poor coordination disrupt execution.

5. Blind Spots And Blocked Ports: Surviving Clinical Supply Friction In LATAM And APAC 5/18/2026

   Clinical trials in LATAM and APAC face hidden supply and data friction as customs, regulations, and IT barriers disrupt forecasting, logistics, and study integrity.

6. Truth: Clinical Supply Is Often The First To See The Whole Picture 5/15/2026

   Clinical supply sees trial risk first when assumptions meet reality. Learn how misalignment forms, why it persists, and how to fix it before delays hit.

7. The $122 Billion Question: Can Clinical Trial Supply Systems Keep Pace With Cell Therapy Demand? 5/14/2026

   Cell therapy demand is outpacing manufacturing capacity, forcing clinical supply teams to rethink patient scheduling, production slots, and real-time coordination.

8. How Real-World, Real-Time, And Synthetic Data Are Revolutionizing Clinical Trial Supply Chains 5/11/2026

   Real-time, real-world, and synthetic data are turning trial supply chains into proactive systems that reduce waste, improve forecasting, and ensure patients get therapies faster.

9. The Atlantic Divide: Forcing FDA Demographics Onto European Supply Chains 5/8/2026

   FDA demographic mandates can upend global trial supply, stranding inventory, driving panic packaging, and creating hidden bias that undermines study execution.

10. Expanding Clinical Trials In Africa Without Disruption 5/7/2026

    A structured five-layer framework helps sponsors expand clinical trials in Africa with clarity, reducing risk, strengthening governance, and improving ROI.